Article thumbnail

Role of Hypothalamic Melanocortin System in Adaptation of Food Intake to Food Protein Increase in Mice

By Bruno Pillot, Céline Duraffourd, Martine Bégeot, Aurélie Joly, Serge Luquet, Isabelle Houberdon, Danielle Naville, Michèle Vigier, Amandine Gautier-Stein, Christophe Magnan and Gilles Mithieux

Abstract

The hypothalamic melanocortin system—the melanocortin receptor of type 4 (MC4R) and its ligands: α-melanin-stimulating hormone (α-MSH, agonist, inducing hypophagia), and agouti-related protein (AgRP, antagonist, inducing hyperphagia)—is considered to play a central role in the control of food intake. We tested its implication in the mediation of the hunger-curbing effects of protein-enriched diets (PED) in mice. Whereas there was a 20% decrease in food intake in mice fed on the PED, compared to mice fed on an isocaloric starch-enriched diet, there was a paradoxical decrease in expression of the hypothalamic proopiomelanocortin gene, precursor of α-MSH, and increase in expression of the gene encoding AgRP. The hypophagia effect of PED took place in mice with invalidation of either MC4R or POMC, and was even strengthened in mice with ablation of the AgRP-expressing neurons. These data strongly suggest that the hypothalamic melanocortin system does not mediate the hunger-curbing effects induced by changes in the macronutrient composition of food. Rather, the role of this system might be to defend the body against the variations in food intake generated by the nutritional environment

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3081342
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1981). Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat.
  2. (2000). Cholecystokinin and satiety: current perspectives.
  3. (1991). Development of muscle insulin resistance after liver insulin resistance in high-fatfed rats.
  4. (2005). Divergence of melanocortin pathways in the control of food intake and energy expenditure.
  5. (2004). Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes.
  6. (1990). Effects of a high-protein meal (meat) and a high-carbohydrate meal (vegetarian) on satiety measured by automated computerized monitoring of subsequent food intake, motivation to eat and food preferences.
  7. (2002). Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression.
  8. (1997). Effects of recombinant agouti-signaling protein on melanocortin action.
  9. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach.
  10. (2002). Gut hormone PYY(3–36) physiologically inhibits food intake.
  11. (2010). Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity.
  12. (2011). Implication of the melanocortin-3 receptor in the regulation of food intake.
  13. (2002). Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet.
  14. (1996). Leptin enters the brain by a saturable system independent of insulin.
  15. (2008). Leptin infusion and obesity in mouse cause alterations in the hypothalamic melanocortin system.
  16. (2000). Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity.
  17. (2010). Metabolic and melanocortin gene expression alterations in male offspring of obese mice.
  18. (2004). Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3–36).
  19. (1993). Molecular cloning, expression, and gene localization of a fourth melanocortin receptor.
  20. (2006). Molecular determinants of energy homeostasis.
  21. (2005). NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates.
  22. (2007). NPY/AgRP neurons are not essential for feeding responses to glucoprivation.
  23. (2000). Obesity in the new millennium.
  24. (2004). Obesity Wars: Molecular Progress Review. Confronts an Expanding Epidemic.
  25. (2002). Obesity: keeping hunger at bay.
  26. (2004). Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein.
  27. (2005). Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein.
  28. (2009). Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin.
  29. (2007). Solid and liquid obesogenic diets induce obe- sity and counter-regulatory changes in hypothalamic gene expression in juvenile Sprague-Dawley rats.
  30. (1970). Subcutaneous dialysis in the study of the effects of nutrients on feeding.
  31. (1997). Targeted disruption of the melanocortin-4 receptor results in obesity in mice.
  32. (2002). The catabolic action of insulin in the brain is mediated by melanocortins.
  33. (2005). The inhibitory effects of peripheral administration of peptide YY(3–36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagalbrainstem-hypothalamic pathway.
  34. (2005). The new functions of the gut in the control of glucose homeostasis.
  35. (2005). The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats.
  36. (1988). The specificity of satiety: the influence of foods of different macronutrient content on the development of satiety.
  37. (2003). Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter.